Two Positive Phase III RCC Studies, Nivolumab Approved for NSCLC in Europe, and More
Tara Petersen reports on phase III findings for cabozantinib and nivolumab as treatments for renal cell carcinoma, a European approval for nivolumab in squamous non-small cell lung cancer, and updates on blinatumomab in acute lymphoblastic leukemia.
Watch video Two Positive Phase III RCC Studies, Nivolumab Approved for NSCLC in Europe, and More online without registration, duration hours minute second in high quality. This video was added by user OncLive 24 July 2015, don't forget to share it with your friends and acquaintances, it has been viewed on our site 389 once and liked it 3 people.